Literature DB >> 18313403

Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients.

Vanessa Battisti1, Liési D K Maders, Margarete D Bagatini, Karen F Santos, Rosélia M Spanevello, Paula A Maldonado, Alice O Brulé, Maria do Carmo Araújo, Maria R C Schetinger, Vera M Morsch.   

Abstract

OBJECTIVES: To evaluate the oxidative status and antioxidant defense in patients with acute lymphoblastic leukemia (ALL). DESIGN AND METHODS: We measured concentrations of plasmatic thiobarbituric acid reactive substances (TBARS), serum protein carbonylation, whole blood catalase (CAT) and superoxide dismutase (SOD) activities, as well as the plasmatic and erythrocyte thiol levels and serum vitamin E concentration. This study was performed on 80 children with ALL divided into 4 groups: just diagnosed, remission induction, remission maintenance and out-of-treatment.
RESULTS: TBARS levels and serum protein carbonylation were higher in ALL patients than in controls and reduced levels of antioxidants were found in these patients.
CONCLUSION: These findings may indicate a possible link between decreased antioxidants and increased levels of cells alterations due to oxidative damage, supporting the idea that there is a persistence of oxidative stress in acute lymphoblastic leukemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313403     DOI: 10.1016/j.clinbiochem.2008.01.027

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  46 in total

1.  S-glutathionylated serine proteinase inhibitors as plasma biomarkers in assessing response to redox-modulating drugs.

Authors:  Christina L Grek; Danyelle M Townsend; Joachim D Uys; Yefim Manevich; Woodrow J Coker; Christopher J Pazoles; Kenneth D Tew
Journal:  Cancer Res       Date:  2012-03-08       Impact factor: 12.701

Review 2.  Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma.

Authors:  Apollina Goel; Douglas R Spitz; George J Weiner
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

3.  Untargeted adductomics of newborn dried blood spots identifies modifications to human serum albumin associated with childhood leukemia.

Authors:  Yukiko Yano; Courtney Schiffman; Hasmik Grigoryan; Josie Hayes; William Edmands; Lauren Petrick; Todd Whitehead; Catherine Metayer; Sandrine Dudoit; Stephen Rappaport
Journal:  Leuk Res       Date:  2019-11-06       Impact factor: 3.156

4.  Bardoxolone Methyl and a Related Triterpenoid Downregulate cMyc Expression in Leukemia Cells.

Authors:  Un-Ho Jin; Yating Cheng; Beiyan Zhou; Stephen Safe
Journal:  Mol Pharmacol       Date:  2017-03-08       Impact factor: 4.436

Review 5.  Integration of hypoxic HIF-α signaling in blood cancers.

Authors:  L Schito; S Rey; M Konopleva
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

6.  Comparing serum levels of zinc, copper, certain antioxidant vitamins and dietary intakes in acute lymphoblastic leukemia (ALL) patients before and after chemotherapy.

Authors:  Camellia Akhgarjand; Kurosh Djafarian; Hamid Rezvani; Eznollah Azargashb; Mohammadreza Vafa
Journal:  Am J Blood Res       Date:  2018-10-05

Review 7.  Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance.

Authors:  S Dalleau; M Baradat; F Guéraud; L Huc
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

Review 8.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

9.  ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.

Authors:  Xiaohua Peng; Varsha Gandhi
Journal:  Ther Deliv       Date:  2012-07

10.  The influence of oxidative stress on symptom occurrence, severity, and distress during childhood leukemia treatment.

Authors:  Marilyn J Hockenberry; Olga A Taylor; Alice Pasvogel; Cheryl Rodgers; Kathy McCarthy; Patricia Gundy; David W Montgomery; Phillip Ribbeck; Michael E Scheurer; Ida M Ki Moore
Journal:  Oncol Nurs Forum       Date:  2014-07-01       Impact factor: 2.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.